Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure

por Mukherjee, Dwaipayan, Chiney, Manoj S., Shao, Xi, Ju, Tzuchi R., Shebley, Mohamad, Marroum, Patrick
Publicado 2022

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended‐Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials

por Mohamed, Mohamed‐Eslam F., Zeng, Jiewei, Marroum, Patrick J., Song, In‐Ho, Othman, Ahmed A.
Publicado 2018

Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse

por Shebley, Mohamad, Menon, Rajeev M., Gibbs, John P., Dave, Nimita, Kim, Su Y., Marroum, Patrick J.
Publicado 2018

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation

por Mohamed, Mohamed-Eslam F., Trueman, Sheryl, Othman, Ahmed A., Han, Jian-Hwa, Ju, Tzuchi R., Marroum, Patrick
Publicado 2019

Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet

por Badawi, Mohamed, Chen, Xin, Marroum, Patrick, Suleiman, Ahmed A., Mensing, Sven, Koenigsdorfer, Anette, Schiele, Julia Teresa, Palenski, Tammy, Samineni, Divya, Hoffman, David, Menon, Rajeev, Salem, Ahmed Hamed
Publicado 2022